$CYTK CYTOKINETICS INC Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CYTOKINETICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in CYTOKINETICS INC. Find out how many shares they currently own, their value and whether they buy or sell their shares.
CYTOKINETICS INC Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| BARBARI SHARON SURREY | EVP, Finance & CFO | 47,640 | 557,388 | shares bought: 18,750 / shares sold: -7,317 | BUY | Mar 02 2017 | |
| BARBARI SHARON SURREY | EVP, Finance & CFO | 24,778 | 289,903 | Feb 26 2014 | |||
| Bhanji Muna | Director | 5,000 | 58,500 | shares bought: 5,000 / shares sold: 0 | BUY | May 13 2021 | 15 months ago |
| Blum Robert I | President & CEO | 361,859 | 4,233,750 | shares bought: 782,521 / shares sold: -457,526 | STRONG BUY | May 07 2021 | 15 months ago |
| Blum Robert I | President & CEO | 3,276 | 38,329 | Feb 26 2014 | |||
| BVF PARTNERS L P/IL | 10% Owner | 3,811,271 | 44,591,871 | shares bought: 342,072 / shares sold: -1,502,984 | STRONG SELL | Dec 11 2020 | 20 months ago |
| Califf Robert | Director | 5,459 | 63,870 | shares bought: 5,204 / shares sold: 0 | STRONG BUY | May 13 2021 | 15 months ago |
| Callos Andrew | EVP, Chief Commercial Officers | 0 | 0 | Apr 05 2021 | 17 months ago | ||
| CHARPENTIER BONNIE | SVP Regulatory & Compliance | 15,000 | 175,500 | shares bought: 35,000 / shares sold: -5,996 | STRONG BUY | Mar 02 2017 | |
| CHARPENTIER BONNIE | SVP Regulatory & Compliance | 0 | 0 | Feb 03 2014 | |||
| COSTA SANTO J | Director | 5,000 | 58,500 | shares bought: 88,331 / shares sold: -83,331 | BUY | May 13 2021 | 15 months ago |
| COSTA SANTO J | Director | 0 | 0 | May 22 2014 | |||
| Cragg David | SVP Human Resources | 160,625 | 1,879,313 | shares bought: 151,666 / shares sold: -40,631 | STRONG BUY | Mar 09 2021 | 17 months ago |
| CREDIT SUISSE FIRST BOSTON/ | 10% Owner | 1,765,683 | 20,658,491 | May 05 2004 | |||
| DOW STEPHEN M | Director | 60,000 | 702,000 | Oct 29 2004 | |||
| DOW STEPHEN M | Director | 3,164,003 | 37,018,835 | Apr 29 2004 | |||
| DOW STEPHEN M | Director | 1,421,052 | 16,626,308 | Jan 04 2013 | |||
| Eastern Capital LTD | 10% Owner | 2,883,845 | 33,740,987 | Feb 27 2014 | |||
| GAGE L PATRICK | Director | 27,529 | 322,089 | shares bought: 52,155 / shares sold: -53,584 | SELL | May 13 2021 | 15 months ago |
| GAGE L PATRICK | Director | 850 | 9,945 | May 22 2014 | |||
| GILBERT DENISE | Director | 0 | 0 | May 21 2015 | |||
| GILBERT DENISE | Director | 0 | 0 | May 22 2014 | |||
| HEIDRICH A GRANT III | Director | 93,755 | 1,096,934 | Jan 05 2011 | |||
| HENDERSON JOHN T | Director | 12,410 | 145,197 | shares bought: 15,524 / shares sold: -9,875 | BUY | May 13 2021 | 15 months ago |
| HENDERSON JOHN T | Director | 0 | 0 | Jan 05 2015 | |||
| HOMCY CHARLES J | Director | 0 | 0 | May 27 2008 | |||
| JAGGERS JOHN V | 10% Owner | 3,164,003 | 37,018,835 | Apr 29 2004 | |||
| Jaw Ching | SVP Finance & CFO | 88,492 | 1,035,356 | shares bought: 127,500 / shares sold: -63,816 | STRONG BUY | Mar 09 2021 | 17 months ago |
| Kaye Edward M. MD | Director | 5,920 | 69,264 | shares bought: 25,409 / shares sold: -20,000 | BUY | May 13 2021 | 15 months ago |
| Malik Fady Ibraham | EVP Research & Development | 160,348 | 1,876,072 | shares bought: 261,666 / shares sold: -112,583 | STRONG BUY | May 13 2021 | 15 months ago |
| MAYFIELD IX | 10% Owner | 13,705 | 160,349 | May 04 2004 | |||
| MCDADE MARK | Director | 0 | 0 | May 22 2009 | |||
| McDowell Caryn Gordon | GC & Chief Compliance Officer | 35,000 | 409,500 | shares bought: 70,416 / shares sold: -44,181 | BUY | Mar 01 2018 | |
| Morgan Bradley Paul | SVP Drug Discovery & Early Dev | 63,107 | 738,352 | shares bought: 153,330 / shares sold: -124,316 | BUY | Sep 01 2017 | |
| MORGANS DAVID J JR | EVP-Preclinical R&D | 42,000 | 491,400 | Mar 01 2011 | |||
| PARSHALL B LYNNE | Director | 5,000 | 58,500 | shares bought: 71,821 / shares sold: -66,821 | BUY | May 13 2021 | 15 months ago |
| PARSHALL B LYNNE | Director | 0 | 0 | Jan 05 2015 | |||
| RABSON MICHAEL | SVP Business Dev/Legal & GC | 20,043 | 234,503 | Dec 21 2009 | |||
| RODDY PETER S | SVP Finance & CAO | 21,520 | 251,784 | shares bought: 20,000 / shares sold: 0 | BUY | Mar 01 2018 | |
| RUTTER WILLIAM J | Director | 172,413 | 2,017,232 | May 03 2004 | |||
| Sabry James H | Director | 0 | 0 | Jun 04 2010 | |||
| SCHLOSSBERG MARK A | SVP - Legal & General Counsel | 50,850 | 594,945 | shares bought: 75,000 / shares sold: -24,150 | STRONG BUY | Mar 09 2021 | 17 months ago |
| SCHMERTZLER MICHAEL | Director | 3,105,261 | 36,331,554 | May 23 2005 | |||
| SCHMERTZLER MICHAEL | Director | 0 | 0 | Jan 06 2009 | |||
| SCHMERTZLER MICHAEL | Director | 5,389,208 | 63,053,734 | May 22 2009 | |||
| SCHMERTZLER MICHAEL | Director | 4,340,923 | 50,788,799 | Jun 04 2010 | |||
| Schnieders Elisabeth | Sr. VP, Business Development | 28,985 | 339,125 | shares bought: 32,500 / shares sold: -5,066 | STRONG BUY | Mar 02 2017 | |
| SEVIN ROSEN FUND VI LP | 10% Owner | 1,615,716 | 18,903,877 | Apr 29 2004 | |||
| SEVIN ROSEN FUND VII LP | 10% Owner | 625,950 | 7,323,615 | Apr 29 2004 | |||
| SEVIN ROSEN FUND VIII LP | 10% Owner | 755,631 | 8,840,883 | Apr 29 2004 | |||
| SEVIN ROSEN VI AFFILIATES FUND LP | 10% Owner | 127,235 | 1,488,650 | Apr 29 2004 | |||
| SEVIN ROSEN VII AFFILIATES FUND LP | 10% Owner | 24,050 | 281,385 | Apr 29 2004 | |||
| SEVIN ROSEN VIII AFFILIATES FUND LP | 10% Owner | 15,421 | 180,426 | Apr 29 2004 | |||
| SMITH SANDFORD D | Director | 5,920 | 69,264 | shares bought: 184,922 / shares sold: -179,513 | BUY | May 13 2021 | 15 months ago |
| SMITH SANDFORD D | Director | 0 | 0 | Jan 05 2015 | |||
| SPUDICH JAMES A | Director | 180,600 | 2,113,020 | May 19 2011 | |||
| SRB ASSOCIATES VI LP | 10% Owner | 1,742,951 | 20,392,527 | Apr 29 2004 | |||
| SRB ASSOCIATES VII LP | 10% Owner | 650,000 | 7,605,000 | Apr 29 2004 | |||
| SRB ASSOCIATES VIII LP | 10% Owner | 771,052 | 9,021,308 | Apr 29 2004 | |||
| TRAUTMAN JAY K | VP, Discovery Research | 47,896 | 560,383 | Mar 04 2008 | |||
| WIERENGA WENDALL | Director | 0 | 0 | Jan 05 2015 | |||
| WIERENGA WENDALL D | Director | 5,920 | 69,264 | shares bought: 15,408 / shares sold: -9,999 | BUY | May 13 2021 | 15 months ago |
| WOLFF ANDREW A | SVP & CMO | 37,239 | 435,696 | shares bought: 27,500 / shares sold: -4,984 | STRONG BUY | Mar 02 2017 | |
| WOLFF ANDREW A | SVP Clinical R&D, CMO | 20,637 | 241,453 | Sep 05 2013 | |||
| Wong Robert | VP, Chief Accounting Officer | 23,879 | 279,384 | shares bought: 20,000 / shares sold: -1,359 | STRONG BUY | Mar 09 2021 | 17 months ago |
| Wysenski Nancy | Director | 5,459 | 63,870 | shares bought: 5,204 / shares sold: 0 | STRONG BUY | May 13 2021 | 15 months ago |